SeaStar Medical Holding Corporation Share Price
ICUSeaStar Medical Holding Corporation Stock Performance
Open $0.33 | Prev. Close $0.35 | Circuit Range N/A |
Day Range $0.33 - $0.35 | Year Range $0.30 - $3.07 | Volume 25,592 |
Average Traded $0.34 |
SeaStar Medical Holding Corporation Share Price Chart
About SeaStar Medical Holding Corporation
SeaStar Medical Holding Corporation, a commercial-stage medical device company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis. It also develops NEUTRALIZE-AKI, an SCD therapy that is in clinical trials for adult patients with AKI; and other products in various therapeutic areas, including cardiorenal syndrome, hepatorenal syndrome, and myocardial stunning in end-stage renal disease. SeaStar Medical Holding Corporation was founded in 2007 and is headquartered in Denver, Colorado.
SeaStar Medical Holding Corporation Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
04-Dec-25 | $0.33 | $0.35 | +0.00% |
04-Dec-25 | $0.33 | $0.35 | +4.78% |
02-Dec-25 | $0.30 | $0.34 | +8.06% |
01-Dec-25 | $0.30 | $0.31 | -0.64% |
28-Nov-25 | $0.30 | $0.31 | +2.30% |
26-Nov-25 | $0.34 | $0.30 | -6.15% |
25-Nov-25 | $0.31 | $0.33 | +5.86% |